Carevive Systems (Carevive), the leading oncology-focused health technology company centered on understanding and improving the cancer patient experience, has today announced the completion of a Series C equity investment of $18 million.


Carevive Systems, founded in 2013, is an oncology-focused health technology company focused on understanding and improving the cancer patient experience. Our platform enables providers to monitor and manage their patients remotely, which improves survival outcomes and patient quality of life. Use of Carevive in the clinic unlocks critical data on the real-world cancer patient experience to continuously improve patient care today and advance cancer drug development. For more information, please visit www.carevive.com or follow us @carevive.

Carevive Closes Oversubscribed $18M Series C Equity Raise

Description

Company Information

Funding Insights

Carevive Closes Oversubscribed $18M Series C Equity Raise

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information